26 August 2019

The Secretary The Manager, Listing Department, Listing Department, BSE Limited, The National Stock Exchange of Ltd 1st Floor, Phiroze Jeejeebhoy Towers Exchange Plaza, C-1, Block G Dalal Street, Mumbai 400001 Bandra Kurla Complex Scrip Code: 540975 Bandra (East), Mumbai 400051 Scrip Symbol: ASTERDM

Dear Sir/Madam,

Sub: Investor Presentation for Capital Market Day

With reference to the captioned subject and the announcement made by the Company on August 8, 2019 relating to the Capital Market Day, which was scheduled for August 22, 2019, please find enclosed the Investor Presentation made.

Kindly take the above said information on record as per the requirement of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Thanking You.

Yours faithfully

For Aster DM Healthcare Limited

Puja Aggarwal Company Secretary and Compliance Officer

Aster DM Healthcare Limited CIN- L85110KL2008PLC021703 IX/475L, ,Kuttisahib Road Near Kothad Bridge, South Chittoor PO Cheranalloor, - 682027, , India Tel: +91 484 6699999, Fax: +91 484 6699862 Email:[email protected]

ASTER OM HEALTHCARE Investor and Analyst Meet – 22nd Aug 2019

www.asterdmhealthcare.com1 I I Disclaimer

 This presentation has been prepared by Aster DM Healthcare Limited (the "Company"), content of which was compiled from sources believed to be reliable for informational purposes only and are based on information regarding the Company and the economic, regulatory, market and other conditions as in effect on the date hereof. Subsequent developments may impact the information contained in this presentation, which neither the Company nor its advisors or representatives are under an obligation to update, revise or affirm. Contents in the Presentation does not constitute or form part of an offer or invitation for sale or subscription of or solicitation or invitation of any offer to buy or subscribe for any securities, nor shall it or any part of it form the basis of or be relied on in connection with any contract, commitment or investment decision in relation thereto in India, the United States or any other jurisdiction.

 Prospective andClinicsexisting investors should make their own evaluation of the Company as the information provided here does not purport to be all inclusive or to contain all of the information$a prospective1 or existing investor may desire. Interested parties shall conduct their own due diligence and investigation on the information, before relying and acting thereon.₹Company6 makes no representation or warranty as to the accuracy or completeness of this information and shall not have any liability for any representations (expressed or implied)0% regarding information contained in, or for any omissions from, this information or any other written or oral communications transmitted to the recipient in the course of its evaluation of the Company.

 This presentation may contain certain "forward looking statements", which are based on certain assumptions and expectations of future events. Actual future performance, outcomes and results may differ materially from those expressed in forward‐looking statements as a result of a number of risks, uncertainties and assumptions. Though such forward‐looking statements are based on reasonable assumptions, it can give no assurance that such expectations will be met. Neither the Company nor any of its advisors or representatives assumes any responsibility to update forward-looking statements or to adapt them to future events or developments.

2 I I Aster DM Healthcare – At a Glance

CAPACITY BEDS One of Largest Private GCC: 1,101 GCC: 12 healthcare service providers 25 4,794 India: 3,693 India: 13 operating in Asia (GCC& India)

PATIENT VISITS – FY19 Present in 9 Countries CLINICS (UAE, Saudi Arabia, Qatar, Oman, ~18.5 mn GCC: ~16.5 mn India: ~2.0 mn GCC: 107 Bahrain, Philippines, Kuwait, 115 India: 8 Jordan and India) REVENUE – FY19 USD 1.14 bn GCC: USD ~953 mn Largest No. of Medical India: USD ~188 mn PHARMACIES Centers / Polyclinics in GCC GCC: 231 231 HUMAN RESOURCE Largest chain of Pharmacies in the UAE Total Facilities 371 t t i DOCTORS NURSES OTHER 20,329 2,913 6,475 10,941

Notes: 1. Revenue shown above excludes other income; 2. Capacity beds shown above excludes O&M beds of WIMS which was included in bed count in the previous presentations 3 3. The above shown doctor count includes professional fee doctors (~1230)working in our India hospitals I I Aster DM Healthcare – Evolution

FY-1987 FY-2012 FY-2019 25 years 7 years

Single clinic Geographies: 5 Geographies: 9 operation in Dubai, Units : 7 Hospitals, Units* : 25 Hospitals, UAE 36 Clinics 115 Clinics 82 Pharmacies 231 Pharmacies

Revenue : INR ~1,181 Cr Revenue : INR ~7,963 Cr - : USD ~251 mn - : USD ~1.14 bn

Note: • Unit count as at 30th June 2019 • FY12 INR:USD exchange rate = 47; approximation used. 4 • FY19 INR:USD exchange rate = 69.76 I I ROBUST GROWTH OVER LAST 5 YEARS

Outpatient Count (in mn) Inpatient Count (in '000) Aster DM - Revenue from Operations (INR Cr) 8.7 7.8 218 6.7 202 7,963 5.6 6,721 158 5,931 4.2 125 5,250 3.4 104 3,876 2.2 85 2,871

2.2 2.1 52 58 1,775 2,029 ------FY14 FY15 FY16 FY17 FY18 FY19 FY20Q1 FY14 FY15 FY16 FY17 FY18 FY19 FY20Q1 FY14 FY15 FY16 FY17 FY18 FY19 FY20Q1

..Coupled with capacity creation for further growth, which resulted in an extensive geographical footprint

Operational Beds

3,092 3,370 2,740 # of Units FY14 FY15 FY16 FY17 FY18 FY19 FY20Q1 2,653

Hospitals 10 14 13 18 19 24 25 1,976 1,772 2,179 2,461 Clinics 45 69 87 96 101 114 115 1,335 2,038 1,979 1,306 1,436 Pharmacies 107 166 180 202 207 219 231 917 913 909 Total 162 249 280 316 327 357 371 418 466 540 615 761 FY14 FY15 FY16 FY17 FY18 FY19 FY20Q1 Note: 1. Out-Patient visits mentioned above does not include pharmacy visits ■ GCC ■ India 2. Operational beds shown above excludes O&M beds of WIMS hospital which was included in bed count in the previous presentations 3. GCC hospitals operational beds reduced from 913 as at Mar 31, 2019 to 909 as at Jun 30, 2019 due to minor renovations in two hospitals. 5 I I Aster – A Healthcare Ecosystem

PATIENT LIFE CYCLE MANAGEMANT . Aster, over 30 years, has created a healthcare eco-system across two geographical regions . In GCC region, Aster’s primary care clinics act as the initial touch-points in the patient

i. journey, while pharmacies and hospitals / ~ continue the care ,,••·Ill .MIJillifl I . For complex tertiary care patients are ....1· transferred to Aster’s Hospitals in India 1· / . I ,1· . Indian operations acts as a source of talent (doctors, nurses and other employees) to GCC operations '\ . Within GCC operations, clinic doctors have \ ..... the opportunity to hone their surgical skills \ in Aster’s hospitals \._ ...... '...... ,._ · -· • -■ ......

6 I I Aster DM Healthcare – At a Glance Revenue - FY19 Revenue - FY19

India 17% Pharmacies 27% Hospitals INR ~7,963 Cr 49% -> Clinics GCC 24% 83%

EBITDA - FY19 EBITDA - FY19

India Pharmacies 14% 21% INR ~863 Cr ._____> Hospitals 49% Clinics GCC 30% 86%

Note: 1. Revenue and EBITDA shown above are excluding other income 7 2. Above shown percentage of revenue and EBITDA by hospitals clinics and pharmacies are calculated based on gross segmental numbers before allocation of inter-segment revenue and unallocated corporate overheads I I ASTER – OUR VISION, VALUES AND PROMISE

VALUES r,JA 1CarE · Excellence Compassion

Wirth a Global . r io . Surpassing current benchmarks constantly by Going beyond boundaries with empathy and continually challenging our ability and skills care to take the organization to greater heights

Patients

Integrity • I Respect ~ RMOMIH Doing the right thing without any Treating people with utmost dignity, valuing "We'll Treat Y□ ,'ellt compromise and embracing a higher 'i;f. their contributions and fostering a culture A promiS'e tihat s standard of conduct that allows each individual to rise to their Society and :,r we exist one wa to Employees fullest potential honour awry .ail(. e\!llry rmment

Passion Unity

/ Harnessing the power of synergy and Going the extra mile willingly, with a Stakeholders complete sense of belongingness and engaging people for exponential purpose while adding value to all our performance and results stakeholders.

8 I I ASTER – Strategy & Outlook (1/2)

 Strengthening of hub and spoke model in GCC

 Specialized, asset-light growth in India

 Cost Optimization – HR & material cost focus

 Profitability growth & brand positioning using product-mix and technology

9 I I ASTER – Strategy & Outlook (2/2)

 Scalable systems implementation, tightly integrated with market requirements

 A comprehensive human resource strategy utilizing our geographical diversity

 Strengthening of our medical tourism network

 Establishing new related business lines

10 I I Aster – Leadership Team , ' Chairman & Managing Director Dr.

\... I

,, F 'I r r 'I CEO CEO Exec. Director & Group Head Deputy Managing Director Group Chief Medical and Aster Primary Care Aster Hosp. & Clinics India - Gov. & Corp Affairs ~ ~ Alisha Moopen Quality Officer [ Jobilal Vavachan Dr. Harish Pillai TJ Wilson Dr. Malathi A ] \. ~ \. ,, ~ I 'I r 13 CEO Aster Pharmacies Group CFO Hospitals - ~ Chief Innovation Officer Medcare H & C, UAE Sreenath Reddy Andre Daoud I Dr. Satish Rath -{ ] ~ \. ~ Aster Clinics 8 ,, 'I Clinics r

- CEO, Aster Hospitals UAE Group CIO Dr. Sherbaz Bichu Veneeth P ~

\. \.

Oman, Qatar and Saudi * * Arabia H & C CPO Group Chief HR Officer -{__ ] [_][_]Antony Petit Fara Siddiqi

Note: * CPO and Group Chief HR Officer and will be reporting to the Deputy Managing Director in line with Succession Planning 11 Aster – GCC

9 I I GCC – Macro Economic Overview

Population (in mn) GDP per Capita - Nominal (USD)

69,000 33.7 • GCC Countries have a high per capita GDP even compared to USA (USD 43,000 ~63,000) and UK (USD ~43,000) 34,200

23,200 24,100 9.6 10.0 • Higher per capita income makes high 16,400 healthcare service offerings affordable 4.8 4.1 2.8 1.6 4,200 I ■ • I • GDP growth (CAGR) in the majority of UAE Oman Qatar Saudi Arabia Bahrain Jordan Kuwait■ - I UAE Oman Qatar SaudiI Arabia BahrainI Jordan- KuwaitI the GCC countries have been between ~2.5% and 3% in the last 5 years, which is similar to growth rates of GDP - Nominal (USD bn) developed countries GDP Growth CAGR 2013 - 2018(%) 782

3.2% 414 2.9% 2.7% 2.6% 2.2% 2.3% 192 142 79 I 38 42 0.3% IUAE Oman• Qatar Saudi Arabia Bahrain-Jordan -Kuwait I UAE Oman Qatar Saudi Arabia Bahrain Jordan Kuwait

Source: World Bank Data Note: Jordan has been included in GCC due to its geographical presence I I GCC – Macro Economic Overview

Healthcare Expenditure (USD bn) Beds / 1000 Population 45 • GCC Countries, especially UAE, Oman 2.9 2.7 2.8 and Qatar have room for growth in

2.0 2.0 terms of healthcare expenditure (% of 1.6 GDP), Beds / 1000 and Physicians / 1.4 15 1.2 1.2 1000 0.7 6 6 3 2 2 I IUAE Oman••Qatar Saudi Arabia Bahrain--Jordan Kuwait■ UAE111Oman Qatar Saudi Bahrain JordanI Kuwait India USA UK Arabia

Healthcare Expenditure (% of GDP) Physicians / 1000 Population 17.1 3.4

2.8 2.6 2.6 2.6 9.8 1.9 2.0 1.6 5.7 4.9 5.5 4.3 3.9 0.9 3.5 3.1 3.7 0.8 1111111 1 I I UAE Oman Qatar Saudi Bahrain Jordan Kuwait India USA UK IllUAE Oman Qatar Saudi Bahrain Jordan Kuwait India USA UK Arabia Arabia

Source: World Bank Data Note: Jordan has been included in GCC due to its geographical presence I I GCC Healthcare – Unique Traits

Population (mn)  Prevalence of Primary and Secondary Healthcare Expat% -> ~80% ~70% ~45% ~30% Facilities (Private Sector) 32.0

9.3  Due to lack of support systems (family, relatives, etc.) 4.4 2.6 expat community travel back to their home countries for

UAE Qatar Oman Saudi Aabia major health concerns

■ Expats ■ Nationals  Seasonality of Patient Volumes: Decline in volumes across

Population Age (%) hospitals, pharmacies and segments during the summer 1% 1% 2% 3% months in the GCC countries

85% 85% 76% 71%  Increase in revenue in H2 results in proportionately larger increase in profitability due to operating leverage. 14% 14% 22% 26%

UAE Qatar Oman Saudi Aabia

■ >=65 (%) ■ 15 -64 (%) ■ <=14 (%)

Source : World Bank (2016 data) 15 I I GCC Healthcare – Chronic Disease Prevalence (Dubai)

 Mortality rate due to cardiovascular diseases (~148 per 10K) – 3x compared to UK or Australia

 Diabetes prevalence ratio 17.3% (age 20-79) – 2x to 4x compared to UK or Australia

 Overweight prevalence ratio 34.5%– 5x to 10x compared to Singapore or Japan

 Cigarette smoking adults - ~22%

Source: DHA 15 I I Aster GCC – Business Split

REVENUE - FY19 Saudi Arabia Others Qatar 6% 2% 5% UAE: 7 Hospitals, 85 Clinics, 198 Pharmacies Oman 6%

UAE Oman: 3 Hospitals, 7 Clinics, 7 Pharmacies 81%

Qatar: 1 Hospital, 8 Clinics, 6 Pharmacies

GCC Revenue FY19: INR ~6,649 Saudi Arabia: 1 Hospital

• ~81% of Aster - GCC revenue is from UAE I I Aster UAE –Overview

Brands/Segments Hospitals Clinics Pharmacies

Count: 4 Count: 17 Installed Beds: 335 Avg Daily Patient Visits:~1,300 Avg Daily Patient Visits: ~1,480 Premium

Count: 3 Count: 47 Count: 198 Installed Beds: 297 Avg Daily Patient Visits: ~8,900 Avg Daily Patient Visits: ~23,000 Aster Avg Daily Patient Visits:~650

Mid I We' ll Treat You We ll

Count: 21 Avg Daily Patient Visits: ~2,300 Lower

Note: All Clinics that are catering to the lower economic segment of the population are included in access category, even if they are of different brands I I Aster UAE – Facilities

Beds : Capacity – 64, Operational - 55 Beds : Capacity – 126, Operational - 108 Operation Commencement Year: FY07 Operation Commencement Year: FY16 City: Dubai City: Dubai

Beds : Capacity – 108, Operational - 91 Beds : Capacity – 154, Operational - 120 Operation Commencement Year: FY17 Operation Commencement Year: FY19 City: Dubai City: Dubai I I Aster Oman

ASTER e ·

·----iii

Beds : Capacity – 85, Operational - 72 Beds : Capacity – 74, Operational - 64 Operation Commencement Year: FY09 Operation Commencement Year: FY10 City: Muscat City: Sohar

• Oman GDP has been growing at a steady ~2.7% from 2013 to 2018 with a relatively high population growth of ~5% • Aster has been present in Oman since 2009 • Aster is a leading healthcare player in Oman with 2 hospitals, 7 clinics and 7 pharmacies

Source: World Bank Data I I Aster Qatar

Beds : Capacity – 61, Operational - 41 Operation Commencement Year: FY18 City: Doha

• Qatar GDP has been growing at ~2.6% from 2013 to 2018 with a population growth of ~3.5% • Aster has been present in Qatar since 2003 and currently has 1 hospitals, 8 clinics and 6 pharmacies

Source: World Bank Data Note: As on 30th June 2019, 28 beds are operational in Aster Hospital, Qatar; Beds will ramp-up to 41; I I Aster - Saudi Arabia

Sanad Hospital – An Overview Sanad Hospital – Snapshot FY 2018-2019

CAPACITY BEDS: 218 t DOCTORS: ~150 @ PATIENT VISITS: 200,000+ t NURSES: ~240 t OTHER HR: ~450

Sanad Hospital – Centres of Excellence

. Aster Sanad Hospital started its operation as “Dr. Ahmad Abanamy Hospital” in the Kingdom of Saudi Arabia covering outpatient and inpatient divisions. BARIATRIC SURGERY 0 NEURO & SPINE SURGERY . Sanad Hospital became a part of Aster DM Healthcare group in 2015 . A state-of-the-art multispecialty hospital, Aster Sanad Hospital aims to make a - ORTHOPAEDICS difference with its patient-centric approach to medical care. 0 . It is accredited by Joint Commission International Accreditation (JCIA) and Saudi Central Board of Accreditation for Healthcare Organizations (CBAHI). - e 0 OBSTETRICS & GYNAECOLOGY GENERAL SURGERY r CBAHI Joint Commission """"".:A.luo,,w.c»~,...... ,'AJ.o-1 International Saudi Central Board for Accreditation of Healthcare Instit utions - I I Aster – Six Strategic Pillars

Clinical Excellence

Service Innovation Excellence

Business Talent Growth Management

Community Connect

• All stages of strategic actions – planning, execution and measurement – is directed by the six strategic pillars

23 Aster RIMARY CARE

DELIVERING GOOD HEALTH & HAPPINESS ••• Aster Primary Care - The Comprehensive Healthcare Offering

Aster -- (IQ0PT1cs -- Aster nline& -- PHARMACY Aster .J PRIMARY CARE ~ ------~ L Aster Aster CLINIC ■ DIAGNOSTIC

Integrated Service Offerings Seamless Customer Journey

Appointment Booking ~ ,----<1 Contact Centre n----+------.. ,------► ------Aster Online 6 Registration - ~ 0,-:-_·_------· ► ------• (! Integrated network: ' Aster Online Home delivery Aster Clinic -" ---- Aster Pharmacy :' ~S-"=ggg§~ y (jl Vitals ? ·-o ( -~ 9 f ~ ASTER Referral l ______.o ~ t i -- ' HOSPITAL .,. Aster Diagnostic : 6--- ' Secondary ' 0 referral and care ~ Optics ' ~ Diagnostics 0

Access Clinic Aster Optics .. , ------Aster PRI MARY CARE Buisness Philosophy

~-~- .... . The Positioning The Promise The Bonding Emotions

Create a Happier, Affordable We will treat Pride Innovation Healthier Society Healthcare made you well Excellence Accessible Patient-Centricity

Aster PRIMARY CARE Aster Primary Care - Organogram

CEO-APC

Head­ Marketing

Aster PRIMARY CARE Meet the CEO of Aster Primary Care Mr. Jobilal M Vavachan

Jobilal is the influential thought-leader of Aster Primary Care who sits at the helm of re-shaping the model of healthcare across the GCC.

Renowned within the healthcare industry, Jobilal brings over 20 years of experience built on a strong foundation. Jobilal started his healthcare career as a pharmacist before building on his passion for excellent patient experience and care to become the spearhead of an organization.

Jobilal joined Aster OM healthcare in 2005, and grew the retail business from 9 pharmacy units to one of the largest pharmacy networks in the UAE.

Today Jobilal has set a benchmark within the market, introducing a dynamic and comprehensive primary care system that champions preventative healthcare whilst providing a holistic solution for all health and wellness needs.

CORE EXPERTISE

Strategic Planning & Execution Business Development Innovation Marketing I Operations Management

Jobilal has an EMBA from INSEAD and studied General Management & Strategic HR from Indian Institute of Management, Ahmedabad.

Aster PRIMARY CA E Market Size & Growth

Dubai population & concentration of economic segment

10 9.62

Dubai Population 8 Total population of Dubai 2.7m ______Dubai __ [ ______, EBP plan enrolment - 60\ 1.3m Northern Emi rates Population C 6 I Fam1hes with EBP- 0.2m :E 17m .5 : 4.3 Total Market - EBP - 1.Sm •:, Ajman 0.4m .; 4 ::> I FuJairah 0.3m I 2.7 I Umm AI-Quwain 0.1m 2 I ~·.Mtit&b&iMiliN&WH • RAK 0.4m I 1.6 I I Low-Leve l 60'.' 2.6 0 Mid-level 2si 1., ToulUAE : oui,.1 Dub.J Auld n1 Premium 15 0.6 Popul lion I Popu~ on R sld nts Outside oui,. '------~ Total 100'l 4.3

UAE Primary Healthcare Market Emirate

Dubai 1,248 ■ -2,600 Clinics spread across 7 Emirates Public Abu Dhabi 780 ■ Private sector clinics share: 98% with Dubai clinit Sharjah 408 having the highest share foll owed by Abu Dhabi 2% (108) Northern Emirates 164

Total 2,600

Source: Population Bulletin 2016, Government of Duba, j lnforat1on from DHA Aster PRI MARY CARE Clinics - Growth Drivers

APC Clinics 75 75

61 63 65

49

31

FY14 FY15 FY16 FY17 FY18 FY19 FY20_Q1

Relocation and expansion of existing clinics give immediate benefits in Margin the form of revenue and margin growth with a lower operating cost base

Pipeline (committed projects): 13 units* Business Growth Drivers • Clinic & Pharmacy (Expansion/Relocation): 6 • Capacity optimization and expansion • Chrnc & Pharmacy (Greenfield): 9 • New business concepts • Clinic 1ns1de Pharmacy: 2 ► GP clinics ► Super Speciality clinics: Ortho, Dental •Most wi ll be operational in this Financial Year • Revenue generating doctors' addition • Key M&A Note: Of the 107 clinics in GCC as on 30th June 2019, 75 is categorized under ‘Aster Primary Care’ vertical Aster PRIMARY CARE Retail - Growth Drivers

APC Retail

98 155 170 190 194 205 217 • COO & Industry veteran Mr. Bala on board in FY18-19 • New brand additions & foray into generics • Rx Generation for brands/products • Replacing locally sourced products & capturing distributor margin

FY14 FY15 FY16 FY17 FY18 FY19 FY20_Q1

Given higher proportion of CAP, Pipeline units to show positive EBITDA in first year of operation itself

Pipeline (Committed projects): 30 units Expansion strategy : • Clinic Attached Pharmacies (CAP): 12 Upstream & downstream integration • Standalone Pharmacies (SAP) : 8 • Clinic attached units • Optics: 8 • Standalone pharmacies in upmarket areas • Beleaf : 2 • Specialty Retail formats - Optics & Beleaf (Nutrition) • Selective M&A

Note: Of the 231 clinics in GCC as on 30th June 2019, 217 is categorized under ‘Aster Primary Care’ vertical Aster PRI MARY CARE Competitive Advantage

Largest network of 01 Full spectrum of healthcare services l Ipharmacies & clinics

VALUE ADDED SERVICES: E-commerce 02 Presence in key commercial and res1dent1al areas Home care nursing Doctor-on-call facility

Aster Secure Loyalty program with over 03 Strong brand equity Ihalf-a-million active customers

04 Private label and exclusivity l 3 decades of expertise Ion pharma and non-pharma

400+ Doctors Economies of scale: 05 800+ Allied & Nursing Staff IProcurement with impact I 700+ Qualified Pharmacists on margins

Aster PRIMARY CARE We are the UAE's most awarded and loved Health & Wellness Service Provider

0

Shar.1ah Top 10 Business Excellence Award .. 2017

UAE Innovation Award .. 2017

Dubai Human Development Appreciation-Award 2018 .

Dubai Quality Appreciation Award For Aster Clinic -- 2019

Aster PRI MARY CARE Affordable Healthcare Made Accessible

195 4000 18 Pharmacies Employees Optical Stores 71 4 4 Aster Clinics Diagonostic Nutrition Online Centers Stores

Note: The above unit counts excludes clinics & pharmacies in Qatar, Oman, medcare clinics(UAE). Diagnostics are generally classified under clinics; Nutrition stores, optical stores, online unit are generally classified under pharmacies Aster PRIMARY CARE ITAL Dr. Sherbaz Bichu – CEO, Aster Hospitals & Clinics, UAE

Overview

Dr. Sherbaz Bichu is Chief Executive Officer and Specialist in Anesthesia at Aster Hospitals, UAE. Having worked in the field of Anesthesia as well as Hospital administration, Dr. Sherbaz Bichu is well versed with the medical as well as the administrative aspects of hospital operations. On the administrative spectrum, he was actively involved in the development and implementation of hospital information systems, process re-engineering, talent acquisition, hospital operations, quality administration, materials and procurement, as well as other functions related to the delivery of patient care. He was responsible from commissioning Role Band 5B to profitability of the Aster Hospital, Mankhool with three more hospitals in the pipeline. Dr. Sherbaz has been enrolled for Healthcare Management program at the Harvard Business School – 2019-20 Aster Exp : 9.5 yrs.. Total Exp :11+ Years Education

• MBA (Health Management), Symbiosis College, Pune (2018) Chief Executive Officer, Apr ‘2014- Aster Hospitals, UAE • MD Anesthesia (JJM Medical College, Davangere, Karnataka, India, Class of 2010) Present • MBBS (JSS Medical College, Karnataka, India, Class of 2003

COO Top Strengths 2014-2018 Aster Hospitals, Mankhool Driving Patient Excellence Driving Collaboration

Consultant – Anesthesia 2010-2014 & Asst. Medical Strong Business Alignment Fostering Innovation Administrator, Malabar Institute of Building Partnerships Medical Sciences Result Driven Aster Hospital UAE Growth Curve

Aster Hospital Sharjah 2020 - 418 BEDS

Aster Hospital Muhaisnah 2019 - 338 BEDS

Aster cedars Hospital 2019 - 297 BEDS

Unit Beds Aster Hospital Qusais 2018 - 280 BEDS Al Rafa 14 Aster Hospital, Mankhool 126 Aster Hospital Mankhool Aster Hospital, Qusais 154 2014 -126 BEDS Aster Cedars Hospital, Jebal 17 Ali Al Rafa Aster Hospital, Muhaisnah 41 Hospital 2005 - 14 Aster Hospital, Sharjah 80 BEDS Recent changes in Healthcare sector

• Ease of licensing - Prometric • Mandatory Insurance in place • Focus on Health Tourism - 326,000 Health tourists were welcomed in Dubai in 2016, DHA aim is to reach 500,000 by 2020. • Focus on e-prescription and electronic data interchange. Aster HOSPITAL We'll Treat You Well

Aster Hospital, Al Mankhool, Aster Hospital, Al Qusais Aster Cedars Hospital, Kuwait Road, Bur Dubai, 9th Beirut Street, Street No 2 (Outside Gate No 2) Dubai - UAE Al Qusais, Dubai - UAE Dubai - UAE Aster Hospital footprint in UAE

SAIF...... ZONE .,.,,,..,Uii..i•.,N, .. __,, UNNERSITY...... cm

Duba, A International Y Airport ALIWIAMA ~> ., Lb.o ..,,sJI _,J.,_,JI

AL KHAWANEEJ o-,1.,JI DUBAI Ft:$TIVAL CITY MIADfF ,...... J,,. Dubai Jebel Ali ~::,

Al Aweer _.JI INT£ANATIONAL NAO Al cm UMMSOOEIM SIUDA 1 ,.._,, 11.....1, NADAL.SHEBA t....JI ... ALOUOZ.... THE PALM JUMEIRAH '-"'- ACADEMIC...... CITY ~,IS\,

ALBARSKA THEYIUA ,l......

MOTORCrTV Lahbab v4J JEBELAU VILLAGE ...J.&.J- ...... ,,

Palm Jebel Ali .,,.Jcj->

IN.A JEBEL All DUBAI ..,J INVESTMENTS PARK -·­,i...... \U

Al Lisalli ..,J....JJI Jebel Ali Business Model

Q Aster based clinic • • Community Clinic

···•···• . .-,., ...... n ··········Y Q Banking on tertiary • • and quaternary case Visiting doctors from India Differentiator – Our Uniqueness (Aster Hospital, Mankhool, Dubai) Clinical • USB: Critical Care, Interventional Cardiology • Center of Excellence – NICU • Royal college of Physicians, London Accredited.

Operational • Sustained occupancy rate > 90% • OT Utilization 100% • Radiology Utilization 92% • ALOS Avg: ~2 • Innovation & Automation projects

Workforce • Low Clinician Attrition rate - 6% YTD • Effecting Clinician Sourcing from Indian market • Doctor Deployment based on project population need analysis • Sound Clinician Reserves: driven by CEO Key Focus Area

Diagnostic Health and Electronic HUB to remote manage monitoring Center of Excellence Insurances NICU/ Cardiology Home care

Transplants

Complex surgical/ Obstetric cases Medcare Hospitals & Medical Centres Innovation Marketing Operations Digitalization Strategy

26 Years of Experience Strategic Partnerships • Regionally & Internationally Design ANDRE Healthcare Ecosystems DAOUD • 15 Years Experience e-business Business in Healthcare Development Medcare Hospitals & Medical Centres International Insurance Network Management GROWTH STORY

• Medcare Hospital • Medcare Orthopaedics • Medcare Hospital • Medea re Women & & Spine Hospital Children Hospital • Medcare Women & Children Hospital • Medcare Orthopaedics • Medcare Hospital Sharjah • Medcare Hospital Sharjah & Spine Hospital

1.1+ MILLION 400+ 2,000+ Clinical Excellence Patient safety and well being to be priority number one Apply international Standards treat patients with Empathy and Attention

Patient Experience Understand and create Patient needs Disrupt industry through a seamless, unique and digital patient experience from start to end

Sustainable Business Model Diversify revenue streams and optimize costs Identify new, unique, scalable revenue streams and optimize cost through revenue sharing partnership models Revenues / Savings BRAND Quality Engagement Digitalization

Introduce tier 1 HIS Referral system / CBD Brand position / Ambition Map patient journey Engage & Enable Increase online revenues Disease management Digital focused strategy Center of Excellence Talent Development Patient portal Sustainable insurance model Editorial plan Clinical Affiliation Rewards Mobile APP Telehealth PR approach Reward on quality Talent Acquisition Feedback and rating tools Geo Expansion / M & A’s Events calendar NPS scores HR Operations CRM concierge services Internal / External com HR Digitalization Introduce chatbots & AI Aster – India

9 Aster India Leadership Team Aster India Leadership Team

Dr. Harish Pillai Dr. Nitish Shetty Jayaprakash KR CEO – Aster India CEO – Aster Hospitals COO – Aster Labs & Clinics, Bengaluru

Kalappa K B Bindu Nambisan Sunil Kumar M R Head HR - Aster India Head – L&OD, Head Finance – Aster India Aster India

50 FootprintGeographical in India Footprint of Aster India Kerala 5 Aster Medcity Hospitals - 13 Aster MIMS Calicut Clinics - 8 INDIA Aster MIMS Kottakal Aster MIMS Kannur ASSH Wayanad

Karnataka 2 Aster CMI Hospital Aster RV Hospital Clinics [4]

Maharastra 1 Aster Aadhar Hospital

Telangana 1 Aster Prime Hospital

Andhra Pradesh 4 Aster Ramesh Hospital - Main Branch Aster Ramesh Hospital - Labbipet Aster Ramesh Hospital - Guntur Aster Ramesh Hospital – Ongole Clinics [4] 51 Aster India @ Glance

. Total Hospitals : 13 Human Resource Cluster wise Revenue Mix . Total Clinics : 8

26% 53% Kerala Cluster

. Capacity Beds : 3693 Doctors Nurses Others Bangalore Cluster . Operational Beds : 2461 10,526 1,570 4,033 4,923 21% Others

Payer Mix % Speciality Mix % CARDIAC SCIENCES MULTI SPECIALITY 6% Walk-in 19% NEURO SCIENCES 63% Corporate 5% 9% 19% GASTROENTEROLOGY AND ILC 6% TPA & Insurance AND 6% 18% Governtment Schemes ORTHOPAEDICS 6% 4% MVT 13% WOMEN'S HEALTH 7% 7% 12% CHILD AND ADOLESCENT HEALTH • The Count of Hospitals, Clinics, Capacity Beds, Operational Beds and Human resource pertains to Q1 FY20. • The Cluster wise revenue mix and Payer mix % is as per Q1 FY20. OTHERS • The Speciality mix of Aster India, is the broad mix among the major COEs. 52 KEY FINANCIAL RATIOS

Calicut, Kottakal & Vijayawada, Guntur & 670 Beds 509 beds 250 beds 175 beds 150 beds Kannur ~ 1209 Beds Ongole ~740 Beds

JCI Accredited 1st NABH Hospital in India NABH Accredited NABH Accredited NABH & NABL Accredited NABL & NABH Accredited

- Da Vinci Surgical Robot - Da Vinci Surgical Robot - Intra Operative MRI - ICCA - 40 high end critical care - 256 Slice CT - Da Vinci Surgical Robot - True Beam Linac - Bi-Plane Hybrid - Hybrid Cathlab - Biplane Hybrid Cathlab beds -3T Whole Body MRI Cathlab with Neuro - True Beam Linac Navigation system

Gastroenterology, Womens Health, Gastroenterology, Neurosciences, Cardiac Sciences, Neurosciences, Neurosciences, Orthopaedics, Orthopedics, Oncology, Neurosciences, Othopedics, Oncology, Orthopedics, Cardiac Gastroenterology, Cardiac Sciences, Cardiology, Orthopedics, Cardiac Sciences, Gasroenterology, Critical Cardiac Sciences, Sciences, Neurosciences & Cardiac Neurosciences Neurosciences Critical Care, Child & Care Medicine, Multi Critical Care, Multi Gastroenterology Sciences. Adolescent Health, Organ Transplant Organ Transplant Urology & Nephrology, Multi Organ Transplant

53 Aster India Clinical Volumes & Case Mix

1,35,500+ 1,790+ IP Discharges Cardiovascular Surgeries

6,470+ 50+ General Surgeries Bariatric Surgeries

570+ 1,180+ Spine Surgeries Joint Replacements

4,260+ 280+ Urology Cases Transplants*

8,500+ 2,700+ Deliveries

2,950+ 1,390+ Gastro-Intestinal Surgeries Plastic Surgeries 54 *Transplants includes kidney, heart, liver, pancreas, etc. | Above numbers are for the financial year FY19 OperationalAster Trending India Growth Trending

Revenue from Operations

1,400 1,314

1,200 1,167

1,000 950

800 632 600 428 400 295

200

- FY14 FY15 FY16 FY17 FY18 FY19

• Aster India CAGR is higher than the Industry CAGR.

55 OperationalAster TrendingIndia Operational Nos Trending

Capacity Beds Operational Beds ARPOB

3460 2179 26100 2038 1979 23700 3071 3007 22175 2548 19052 1436 2007 1306 15936 CAGR : 27% 12,643 917 CAGR : 19% CAGR : 16% 1,036

FY14 FY15 FY16 FY17 FY18 FY19 FY14 FY15 FY16 FY17 FY18 FY19 FY14 FY15 FY16 FY17 FY18 FY19

OP Nos IP Nos

1,717,851 135,500 1,581,168 131,800 1,453,920 111,548 1,156,978 85,878 972,970 814,950 69,382 57,104 CAGR : 16% CAGR : 19%

FY14 FY15 FY16 FY17 FY18 FY19 FY14 FY15 FY16 FY17 FY18 FY19 56 Note: Above details excludes India clinics India StrategyBUSINESS – Way GROWTH Forward – HOSPITALS

Locations for Flagship Units in Tier 1 cities and Metros

Manpower estimate for FY 2025 – 20,000 57 India Strategy Long-term lease or an India Strategy O&M model to Focus on hospital enable better driven operating ROCEs model vs India is ‘Superstar doctor’ geographically driven operating The Pradhan Mantri Jan Arogya Yojana well positioned for model (PM-JAY) will cover around 500 million medical tourism beneficiaries across the country, and lead from the GCC Aster to significant improvement in capacity states, MENA DM Hospitals utilization in Indian hospitals and enable region and South- consistently scope for further expansion East Asia amongst the . GDP spent on healthcare in India is top in google very low and there is significant rankings and demand supply gap patient . Low affordability and insurance endorsements – penetration are major reasons why Visibly growing healthcare hasn’t taken off appreciation in . PM-JAY will enable newer operating India for quality models to capture emerging healthcare ,clinical opportunity – suit your pocket, excellence and assisted living, etc. patient service View entry of regulator in Indian healthcare as a Leverage the rich positive change – pool of Clinical Aster DM has talent in India for extensive tertiary and experience of quaternary care operating in services at group regulated GCC hospitals markets 58 Aster ChennaiBUSINESS GROWTH – HOSPITALS

• 500 beds • Gastroenterology, • Oncology, • Nephrology, • Urology, • , • Women & Child Health

Manpower estimate for FY 2025 – 20,000 59 . Aster Labs FOCUS ON BENGALURU

60 Aster Bangalore

To be a dominant health care provider in Bangalore

61 Advantage - Bangalore

. Bangalore is one of fastest growing market in India, which has highest growth rate Strong Demand compared to other cities. . Bangalore market expected to grow with high CAGR compared to other cities in India

Demographic • Growing population and rising life expectancies – Particularly increasing need for Transformation maternity, child health and geriatric care

Increased . Growing middle class, rising incomes and increased insurance penetration Affordability

Influx of Medical . Currently Bangalore market is serving 15,000 international patients per annum, which are expected to grow tourists

62 Population growth (In Mn)

Bangalore Delhi 34.6 20 40 14.39 29.3 30.2 15 11.88 12.33 30 25.8 10.1 21.9 10 8.2 20

5 10

0 0 2010 2015 2019 2020 2025 2010 2015 2019 2020 2025 Population Population Chennai Mumbai 25.0 14.0 22.0 12.3 20.2 20.4 12.0 10.7 11.0 19.3 9.6 20.0 18.2 10.0 8.5 8.0 15.0 6.0 4.0 10.0 2.0 5.0 - 2010 2015 2019 2020 2025 - Population 2010 2015 2019 2020 2025 Population Data Source : Worldpopulationreview.com 63 “DELIVERING ETHICAL AND • 509AFFORDABLE beds MEDICAL CARE” • NABH Accredited • da Vinci Surgical Robot • DNB Training Programs “DELIVERING ETHICAL AND • ~250AFFORDABLE beds MEDICAL CARE” • Intra Operative MRI • da Vinci Surgical Robot • Bi-Plane Hybrid Cathlab with Neuro Navigation system Thank You

9